Receptor News and Research

RSS

Rates for new cases of kidney failure have stabilized

After 20 years of annual increases from 5 to 10 percent, rates for new cases of kidney failure have stabilized, according to new research from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). At the same time, dramatic racial disparities persist.

11 Oct 2005

Arena Pharmaceuticals issue new patent

Arena Pharmaceuticals has announced that it was issued US patent number 6,953,787, entitled "5-HT2C Receptor Modulators," by the United States Patent and Trademark Office.

11 Oct 2005

Potential new treatment for stroke

"The study was designed to test if IL-1ra is safe in stroke patients and showed promising results," said Professor Rothwell, a world-renowned neuroscientist based in the University's Faculty of Life Sciences.

From The University of Manchester 10 Oct 2005

Researchers find CCL5 protein produced in the course of respiratory viral infections can serve to protect macrophages from an untimely death

Enlisted to help fight viral infections, immune cells called macrophages consume virus-infected cells to stop the spread of the disease in the body.

9 Oct 2005

Gene variation may play fundamental role in the development and spread of cancer in the body

New research shows that a small gene variation that increases the risk of inherited cancer can also arise during the development of spontaneous, or non-inherited, tumors.

9 Oct 2005

Gut antibody could prove to be a promising drug target for Crohn's disease

A collaboration led by the Burnham Institute for Medical Research has found that an antibody which binds to an unusual sugar molecule residing in the gut halts the inflammation seen in Crohn's disease and other intestinal inflammations. The antibody could prove to be a promising drug target for these common chronic intestinal disorders.

9 Oct 2005

Our own mind and body give us the foundation to understand what other people are doing, thinking, or feeling

Successful social communication is based, above all, on the ability to understand the actions of other people. But how can we imagine what other people are thinking, or what intentions they have? Psychologists and neuroscientists trace it back to a kind of simulation that goes on in our brain as soon as we observe a person acting.

5 Oct 2005

GRK5 protein plays important role in hypertension

Researchers at Jefferson Medical College have implicated a protein called GRK5 as having an important role behind essential hypertension, which affects more than 65 million Americans.

5 Oct 2005

Researchers "should rethink what they are doing" in creating drugs based on a fruit-fly model

The first close-up look at a pro-inflammatory signaling molecule involved in immune response in mammals suggests that researchers "should rethink what they are doing" in creating drugs based on a fruit-fly model, scientists say.

4 Oct 2005

Americans' risk of dying from cancer continues to decline

The nation's leading cancer organizations report that Americans' risk of dying from cancer continues to decline and that the rate of new cancers is holding steady. The "Annual Report to the Nation on the Status of Cancer, 1975-2002," published in the Oct. 5, 2005, issue of the Journal of the National Cancer Institute, shows observed cancer death rates from all cancers combined dropped 1.1 percent per year from 1993 to 2002.

4 Oct 2005

Discovery has implications for research on restoring mobility to people who have lost motor functions due to spinal cord injury

Yale School of Medicine researchers report in Science this week genetic evidence for the hypothesis that myelination, or formation of a protective sheath around a nerve fiber, consolidates neural circuitry by suppressing plasticity in the mature brain.

3 Oct 2005

Researchers set out to determine the effectiveness of endomorphin 1, with a painkilling capacity equal to or greater than morphine

Nearly one third of the world's adult population suffers with the pain of arthritis. While NSAIDs and COX-2 inhibitors offer the promise of relief, these drugs also bring the risk of adverse effects, from stomach ulcers to heart attack.

3 Oct 2005

Lab-made version of a human protein opens a new research avenue to better understand rheumatoid arthritis

A lab-made version of a human protein alleviates symptoms of both acute and chronic arthritis in mice and could be the basis for a new arthritis drug for people, report scientists from the National Institute of Allergy and Infectious Disease (NIAID), part of the National Institutes of Health (NIH).

3 Oct 2005

Research may help create drugs to target the molecule-binding pathway, beneficial for treating arthritis and reducing inflammation

3 Oct 2005

Nanoparticles as an invisible diet

Utah State University researchers are in the early stages of scientifically tricking the body into eating less and finding a treatment for obesity without dangerous side effects.

28 Sep 2005

C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance

New research shows that levels of C-reactive protein (CRP), produced by the liver and not at the lesion site, correlate with the degree of atherosclerosis.

28 Sep 2005

Survival of heart attack patients placed on beta-blocker therapy corresponds to specific variations in their genes

Survival of heart attack and unstable angina patients placed on beta-blocker therapy corresponds to specific variations in their genes, according to a study by researchers at Washington University School of Medicine in St. Louis and the Mid America Heart Institute in Kansas City.

27 Sep 2005

Equine flu virus jumps to dogs

A Cornell University virologist has isolated a highly contagious equine flu virus that is spreading a sometimes-fatal respiratory flu among dogs, and is responsible for a major dog-flu outbreak in New York state. There is no evidence that the virus could infect people.

27 Sep 2005

Possibility of tailored treatments for addiction based on how a person's genes behave

Scientists have learned how a genetic variation long suspected in making some people susceptible to alcoholism and narcotic drug addiction actually does so.

27 Sep 2005

Pursuit of potential drugs and small molecules that target the IGF-1 receptor

Pharmaceutical companies around the world still come knocking on Renato Baserga, M.D.,'s door. And for good reason.

27 Sep 2005

Receptor News and Research

Rates for new cases of kidney failure have stabilized

Arena Pharmaceuticals issue new patent

Potential new treatment for stroke

Researchers find CCL5 protein produced in the course of respiratory viral infections can serve to protect macrophages from an untimely death

Gene variation may play fundamental role in the development and spread of cancer in the body

Gut antibody could prove to be a promising drug target for Crohn's disease

Our own mind and body give us the foundation to understand what other people are doing, thinking, or feeling

GRK5 protein plays important role in hypertension

Researchers "should rethink what they are doing" in creating drugs based on a fruit-fly model

Americans' risk of dying from cancer continues to decline

Discovery has implications for research on restoring mobility to people who have lost motor functions due to spinal cord injury

Researchers set out to determine the effectiveness of endomorphin 1, with a painkilling capacity equal to or greater than morphine

Lab-made version of a human protein opens a new research avenue to better understand rheumatoid arthritis

Research may help create drugs to target the molecule-binding pathway, beneficial for treating arthritis and reducing inflammation

Nanoparticles as an invisible diet

C-reactive protein in atherosclerotic lesions: its origin and pathophysiological significance

Survival of heart attack patients placed on beta-blocker therapy corresponds to specific variations in their genes

Equine flu virus jumps to dogs

Possibility of tailored treatments for addiction based on how a person's genes behave

Pursuit of potential drugs and small molecules that target the IGF-1 receptor

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News